Diphencyprone as a therapeutic option in cutaneous metastasis of melanoma. A single-institution experience
An. bras. dermatol
; An. bras. dermatol;93(2): 299-301, Mar.-Apr. 2018. graf
Article
en En
| LILACS
| ID: biblio-1038267
Biblioteca responsable:
BR1.1
ABSTRACT
Abstract Diphencyprone has been reported as a local immunotherapy for cutaneous melanoma metastases. We aim to report cases of melanoma patients treated with diphencyprone in a single Brazilian institution and highlight their outcomes. Since 2012, we have treated 16 melanoma patients with cutaneous metastases with topical diphencyprone. To date, we have had 37.5% of complete response, 25% of partial responses, and 31.25% patients without any response. Treatment was well tolerated and local toxicity was easily controlled. We believe topical diphencyprone is a feasible treatment that can be another option for treating melanoma patients, especially in cases of in-transit or extensive disease.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
LILACS
Asunto principal:
Neoplasias Cutáneas
/
Ciclopropanos
/
Melanoma
/
Antineoplásicos
Límite:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
País/Región como asunto:
America do sul
/
Brasil
Idioma:
En
Revista:
ABD: Anais brasileiros de dermatologia
/
An Bras Dermatol
/
An. bras. dermatol
/
An. bras. dermatol. (Online)
/
Anais brasileiros de dermatologia (Impresso)
Asunto de la revista:
DERMATOLOGIA
Año:
2018
Tipo del documento:
Article
País de afiliación:
Brasil
Pais de publicación:
Brasil